The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
As of close of business last night, Nuvation Bio Inc’s stock clocked out at $1.75, down -2.23% from its previous closing price of $1.79. In other words, the price has decreased by -$2.23 from its previous closing price. On the day, 4.56 million shares were traded. NUVB stock price reached its highest trading level at $1.775 during the session, while it also had its lowest trading level at $1.62.
Ratios:
To gain a deeper understanding of NUVB’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 9.04 and its Current Ratio is at 9.04. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Jefferies on March 27, 2024, Upgraded its rating to Buy and sets its target price to $10 from $1.40 previously.
On March 26, 2024, BTIG Research Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $5.
Jefferies Downgraded its Buy to Hold on January 06, 2023, whereas the target price for the stock was revised from $5 to $2.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Apr 07 ’25 when Hung David bought 300,000 shares for $1.62 per share. The transaction valued at 487,500 led to the insider holds 58,781,054 shares of the business.
Hung David bought 200,000 shares of NUVB for $332,720 on Apr 04 ’25. The PRESIDENT AND CEO now owns 58,481,054 shares after completing the transaction at $1.66 per share. On Apr 01 ’25, another insider, Mashal Robert, who serves as the Director of the company, bought 100,000 shares for $1.67 each. As a result, the insider paid 166,985 and bolstered with 200,000 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NUVB now has a Market Capitalization of 594420736 and an Enterprise Value of 68429896. For the stock, the TTM Price-to-Sale (P/S) ratio is 75.31 while its Price-to-Book (P/B) ratio in mrq is 1.27. Its current Enterprise Value per Revenue stands at 8.692 whereas that against EBITDA is -0.41.
Stock Price History:
The Beta on a monthly basis for NUVB is 1.44, which has changed by -0.4107744 over the last 52 weeks, in comparison to a change of 0.028231144 over the same period for the S&P500. Over the past 52 weeks, NUVB has reached a high of $3.97, while it has fallen to a 52-week low of $1.54. The 50-Day Moving Average of the stock is -14.45%, while the 200-Day Moving Average is calculated to be -33.00%.
Shares Statistics:
It appears that NUVB traded 2.66M shares on average per day over the past three months and 3571800 shares per day over the past ten days. A total of 336.84M shares are outstanding, with a floating share count of 226.72M. Insiders hold about 33.06% of the company’s shares, while institutions hold 45.74% stake in the company. Shares short for NUVB as of 1741910400 were 28389504 with a Short Ratio of 12.09, compared to 1739491200 on 26169334. Therefore, it implies a Short% of Shares Outstanding of 28389504 and a Short% of Float of 11.73.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
